Related Experiment Videos
[Endothelin system and heart failure: a potential therapeutic target]
Manuel Vaz-da-Silva1, Cassiano Abreu-Lima
1Serviço de Cardiologia, Faculdade de Medicina do Porto, Porto, Portugal.
Summary
Neurohormonal activation, particularly the endothelin system, plays a key role in heart failure. Targeting this system offers a promising therapeutic strategy to improve patient outcomes and reduce mortality.
Area of Science:
- Cardiology
- Endocrinology
- Pharmacology
Context:
- Neurohormonal activation is central to heart failure pathophysiology.
- The endothelin system is increasingly recognized for its significant role in heart failure manifestations.
- Current treatments for heart failure aim to mitigate neurohormonal dysregulation.
Purpose:
- To review the fundamental aspects of endothelin biology and its mechanisms.
- To elucidate the pathophysiological role of the endothelin system in heart failure.
- To discuss the therapeutic potential of targeting the endothelin system in heart failure management.
Summary:
- This review covers endothelin biology, molecular mechanisms, and its pathophysiological involvement in heart failure.
- It highlights the endothelin system's role in heart failure's complex mechanisms.
- Potential pharmacological interventions and clinical trial outcomes are presented.
Impact:
- Endothelin system modulation presents a novel therapeutic avenue for heart failure.
- Understanding endothelin's role can lead to improved treatment strategies for heart failure.
- Pharmacological targeting may reduce morbidity and mortality in heart failure patients.